TNFRSF17 and neoplasm: This was evidenced by the fact that within each tumor, nearly all cells (99.5–99.7%) contained the same BCMA mutation, but the two tumors contained two different BCMA mutations within the CRISPR-edited region (Supplementary Data File 1).